Quantitative acoustic characterization of a new surfactant-based ultrasound contrast agent

Abstract

The acoustic properties of a new ultrasound contrast agent, ST68, have been investigated. ST68 is a sonicated mixture of nonionic surfactants (Span- type and Tween-type) consisting of stabilized microbubbles with a mean diameter of 3.8 μm and a concentration of 7.1 x 108 bubbles/mL. A pulsatile flow system was used to acquire data in vitro. The acoustic properties of ST68, as a function of time, frequency and dose, were calculated. Enhancement changed nonlinearly with contrast agent dose; maximum was 13.1 dB ± 1.0 dB for a dose of 0.30 μL/mL of suspending medium. Attenuation reached approximately 11 dB/cm for dosages above 0.27 μL/mL and for frequencies between 2.5 and 6.0 MHz. In vivo, IV injections of ST68 were given to 4 rabbits (doses from 0.01 to 0.23 mL/kg). A clear increase in flow signal intensity was observed for 1 to 2 min. An in vivo dose-response curve was calculated from audio Doppler signals obtained with a 10-MHz cuff transducer placed around the distal aorta. Maximum enhancement was 18.3 dB ± 3.13 dB for a 0.13 mL/kg dose. Moreover, ST68 appears to follow a simple relationship between in vivo enhancement and dose. In conclusion, ST68 is capable of producing marked vascular enhancement. Its acoustic properties have been characterized in vitro and in vivo.